0001571049-15-006999.txt : 20150824 0001571049-15-006999.hdr.sgml : 20150824 20150824170032 ACCESSION NUMBER: 0001571049-15-006999 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150820 FILED AS OF DATE: 20150824 DATE AS OF CHANGE: 20150824 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PHIBRO ANIMAL HEALTH CORP CENTRAL INDEX KEY: 0001069899 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 131840497 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: GLENPOINTE CENTRE EAST, 3RD FLOOR STREET 2: 300 FRANK W. BURR BLVD., SUITE 21 CITY: TEANECK STATE: NJ ZIP: 07666 BUSINESS PHONE: 201-329-7300 MAIL ADDRESS: STREET 1: GLENPOINTE CENTRE EAST, 3RD FLOOR STREET 2: 300 FRANK W. BURR BLVD., SUITE 21 CITY: TEANECK STATE: NJ ZIP: 07666 FORMER COMPANY: FORMER CONFORMED NAME: PHILIPP BROTHERS CHEMICALS INC DATE OF NAME CHANGE: 19980908 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Carlson Gerald K CENTRAL INDEX KEY: 0001601343 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36410 FILM NUMBER: 151071518 MAIL ADDRESS: STREET 1: 2496 OLD BEACH ROAD CITY: WAYZATA STATE: MN ZIP: 55391 FORMER NAME: FORMER CONFORMED NAME: Carlson Gerald Kenneth DATE OF NAME CHANGE: 20140227 4 1 t1502007_carlson-f4.xml OWNERSHIP DOCUMENT X0306 4 2015-08-20 0 0001069899 PHIBRO ANIMAL HEALTH CORP PAHC 0001601343 Carlson Gerald K 300 FRANK W. BURR BLVD., STE 21 TEANECK, NJ 07666 1 1 0 0 Chief Operating Officer Class A Common Stock 2015-08-20 4 M 0 2500 11.83 A 2500 D Class A Common Stock 2015-08-20 4 S 0 2500 36.5474 D 0 D Class A Common Stock 2015-08-21 4 M 0 13500 11.83 A 13500 D Class A Common Stock 2015-08-21 4 S 0 13500 34.7639 D 0 D Option to purchase Class A Common Stock 11.83 2015-08-20 4 M 0 2500 0 D 2013-04-29 2019-02-28 Class A Common Stock 2500 181550 D Option to purchase Class A Common Stock 11.83 2015-08-21 4 M 0 13500 0 D 2013-04-29 2019-02-28 Class A Common Stock 13500 168050 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2015. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.37 to $36.59, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.95 to $35.38, inclusive. /s/ Thomas G. Dagger, as Attorney-in-Fact for Gerald K. Carlson 2015-08-24